Clinical Study of the Effect of Combined Treatment of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Zileuton (Primary) ; Aspirin
- Indications Lung cancer
- Focus Therapeutic Use
- 21 Sep 2017 Planned number of patients changed from 56 to 66.
- 21 Sep 2017 Planned primary completion date changed from 28 Feb 2018 to 31 Jan 2019.
- 10 Jun 2017 Biomarkers information updated